Biohaven Pharmaceutical Holding Co Ltd. Insider Trading for November 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Biohaven Pharmaceutical Holding Co Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Biohaven Pharmaceutical Holding Co Ltd. for November 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28 2017 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Sell | S | 25.92 | 20,000 | 518,400 | 1,269,699 | 1.3 M to 1.3 M (-1.55 %) |
| Nov 28 2017 | BHVN | Biohaven Pharmaceu ... | Bailey Gregory | Director | Sell | S | 26.02 | 600 | 15,612 | 1,289,699 | 1.3 M to 1.3 M (-0.05 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.61 | 8,938 | 5,452 | 31,962 | |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Option Exercise | M | 0.61 | 21,600 | 13,176 | 40,900 | |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Sell | S | 26.28 | 8,938 | 234,891 | 3,576 | 12.5 K to 3.6 K (-71.42 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.61 | 8,938 | 5,452 | 12,514 | 3.6 K to 12.5 K (+249.94 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Sell | S | 27.37 | 8,517 | 233,110 | 3,576 | 12.1 K to 3.6 K (-70.43 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Sell | S | 26.26 | 13,083 | 343,560 | 12,093 | 25.2 K to 12.1 K (-51.97 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Engelhart James | Chief Financial Off ... | Buy | M | 0.61 | 21,600 | 13,176 | 25,176 | 3.6 K to 25.2 K (+604.03 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.09 | 660 | 16,559 | 522,000 | 522.7 K to 522 K (-0.13 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 24.42 | 26,272 | 641,562 | 522,660 | 548.9 K to 522.7 K (-4.79 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.09 | 164 | 4,115 | 618,000 | 618.2 K to 618 K (-0.03 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 24.42 | 6,568 | 160,391 | 618,164 | 624.7 K to 618.2 K (-1.05 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.22 | 3,680 | 96,490 | 548,932 | 552.6 K to 548.9 K (-0.67 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.55 | 33,589 | 858,199 | 552,612 | 586.2 K to 552.6 K (-5.73 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.22 | 920 | 24,122 | 624,732 | 625.7 K to 624.7 K (-0.15 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 25.55 | 8,398 | 214,569 | 625,652 | 634.1 K to 625.7 K (-1.32 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.31 | 41,861 | 1,101,363 | 586,201 | 628.1 K to 586.2 K (-6.67 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.31 | 10,465 | 275,334 | 634,050 | 644.5 K to 634.1 K (-1.62 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 27.38 | 7,250 | 198,505 | 628,062 | 635.3 K to 628.1 K (-1.14 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.21 | 14,688 | 384,972 | 635,312 | 650 K to 635.3 K (-2.26 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 27.38 | 1,813 | 49,640 | 644,515 | 646.3 K to 644.5 K (-0.28 %) |
| Nov 14 2017 | BHVN | Biohaven Pharmaceu ... | Berman Robert | Chief Medical Offic ... | Sell | S | 26.21 | 3,672 | 96,243 | 646,328 | 650 K to 646.3 K (-0.56 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Option Exercise | M | 0.61 | 5,000 | 3,050 | 57,500 | |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Sell | S | 29.65 | 1,414 | 41,925 | 0 | 1.4 K to 0 (-100.00 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Sell | S | 29.13 | 3,586 | 104,460 | 1,414 | 5 K to 1.4 K (-71.72 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Gentile Kimberly | VP of Operations | Buy | M | 0.61 | 5,000 | 3,050 | 5,000 | 0 to 5 K |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Option Exercise | M | 9.29 | 30,000 | 278,700 | 88,792 | |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 29.63 | 8,653 | 256,388 | 0 | 8.7 K to 0 (-100.00 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Sell | S | 29.10 | 21,347 | 621,198 | 8,653 | 30 K to 8.7 K (-71.16 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Tilton John | Chief Commercial Of ... | Buy | M | 9.29 | 30,000 | 278,700 | 30,000 | 0 to 30 K |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.62 | 6,926 | 205,148 | 575,000 | 581.9 K to 575 K (-1.19 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.10 | 18,074 | 525,953 | 581,926 | 600 K to 581.9 K (-3.01 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.62 | 6,926 | 205,148 | 575,000 | 581.9 K to 575 K (-1.19 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.10 | 18,074 | 525,953 | 581,926 | 600 K to 581.9 K (-3.01 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 30.51 | 1,050 | 32,036 | 600,000 | 601.1 K to 600 K (-0.17 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.96 | 23,123 | 692,765 | 601,050 | 624.2 K to 601.1 K (-3.70 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.04 | 25,827 | 750,016 | 624,173 | 650 K to 624.2 K (-3.97 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 30.51 | 1,050 | 32,036 | 600,000 | 601.1 K to 600 K (-0.17 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.96 | 23,122 | 692,735 | 601,050 | 624.2 K to 601.1 K (-3.70 %) |
| Nov 02 2017 | BHVN | Biohaven Pharmaceu ... | Coric Vlad | Chief Executive Off ... | Sell | S | 29.04 | 25,828 | 750,045 | 624,172 | 650 K to 624.2 K (-3.97 %) |